Jeremy A. Hengst, Ph.D.
Affiliations: | Pennsylvania State University, State College, PA, United States |
Area:
metalloproteinasesGoogle:
"Jeremy Hengst"Mean distance: 9.8 | S | N | B | C | P |
Parents
Sign in to add mentorJudith S. Bond | grad student | 2002 | Penn State | |
(The roles of the EFG-like, transmembrane and cytoplasmic domains of meprin in the secretory pathway.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hengst JA, Dick TE, Smith CD, et al. (2020) Analysis of selective target engagement by small-molecule sphingosine kinase inhibitors using the Cellular Thermal Shift Assay (CETSA). Cancer Biology & Therapy. 1-12 |
Hengst JA, Hegde S, Paulson RF, et al. (2020) Development of SKI-349, a Dual-Targeted Inhibitor of Sphingosine Kinase and Microtubule Polymerization. Bioorganic & Medicinal Chemistry Letters. 127453 |
Hengst JA, Dick TE, Sharma A, et al. (2017) SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia Models. Cancer Translational Medicine. 3: 109-121 |
Desai DH, Kale VP, Hengst JA, et al. (2016) Abstract 4805: In vitro characterization of novel inhibitors of ROCK and MRCK kinases as anticancer agents Cancer Research. 76: 4805-4805 |
Lee S, Hengst J. (2016) DDIS-15. SPECIFIC SPHINGOSINE KINASE 1 INHIBITORS FOR MALIGNANT GLIOMA TREATMENT Neuro-Oncology. 18: vi50-vi50 |
LeBlanc FR, Liu X, Hengst J, et al. (2015) Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia. Cancer Biology & Therapy. 0 |
Kale VP, Hengst JA, Desai DH, et al. (2015) The regulatory roles of ROCK and MRCK kinases in the plasticity of cancer cell migration. Cancer Letters. 361: 185-96 |
Dick TE, Hengst JA, Fox TE, et al. (2015) The apoptotic mechanism of action of the sphingosine kinase 1 selective inhibitor SKI-178 in human acute myeloid leukemia cell lines. The Journal of Pharmacology and Experimental Therapeutics. 352: 494-508 |
Dick TE, Hengst J, Kale V, et al. (2015) Abstract 2933: The apoptotic mechanism of action of SKI-178, a novel Sphingosine kinase 1 selective inhibitor Cancer Research. 75: 2933-2933 |
Kale VP, Hengst JA, Desai DH, et al. (2014) A novel selective multikinase inhibitor of ROCK and MRCK effectively blocks cancer cell migration and invasion. Cancer Letters. 354: 299-310 |